Jan L. Garfinkle

Ms. Jan L.
Garfinkle is a Founder & Managing Partner at Arboretum Ventures LLC and a Director & Managing Partner at Reprieve Cardiovascular, Inc. She is on the Board of Directors at Francis Medical, Inc., Trinity Health System, Bank of Ann Arbor, Koya Medical, Inc., RareCyte, Inc., Arbor Bancorp, Inc. and Reprieve Cardiovascular, Inc. Ms. Garfinkle was previously employed as a Board Observer, Investor by nVision Medical Corp., a Board Member by NeuMoDx Molecular, Inc., a Board Member by Ebb Therapeutics, Inc., a Board Member by NXThera, Inc., a Board Observer by Esperion Therapeutics, Inc., a Vice President by Michigan Venture Capital Association, a President by Strategic Marketing Consultants, Inc., a Principal by Abbott Cardiovascular Systems, Inc., an Advisor by Global Cardiovascular Innovation Center, a Chairman by National Venture Capital Association, a Production Line Manager & Manufacturing Engineer by Procter & Gamble Co., an Advisor by University of Michigan, and a Principal by Vascular Intervention.
She also served on the board at Accord Biosciences, Inc., Cardiac Dimensions, Inc., HandyLab, Inc., Life Magnetics, Inc., Sonitus Medical, Inc. and Strata Oncology, Inc. She received her undergraduate degree from the University of California, Berkeley and an MBA from The Wharton School of the University of Pennsylvania.